131 related articles for article (PubMed ID: 6167711)
21. Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats.
Fuller RW; Snoddy HD; Molloy BB
J Pharmacol Exp Ther; 1986 Nov; 239(2):454-9. PubMed ID: 2430093
[TBL] [Abstract][Full Text] [Related]
22. Anorexia and brain serotonin: development of tolerance to the effects of fenfluramine and quipazine in rats with serotonin-depleting lesions.
Carlton J; Rowland N
Pharmacol Biochem Behav; 1984 May; 20(5):739-45. PubMed ID: 6610879
[TBL] [Abstract][Full Text] [Related]
23. The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats.
Fuller RW; Snoddy HD; Clemens JA
Endocr Res Commun; 1978; 5(2):161-71. PubMed ID: 309816
[TBL] [Abstract][Full Text] [Related]
24. On the role of the central serotoninergic system in the regulation of the secretion of thyrotropin and prolactin: thyrotropin-inhibiting and prolactin-releasing effects of 5-hydroxytryptamine and quipazine in the male rat.
Krulich L; Vijayan E; Coppings RJ; Giachetti A; McCann SM; Mayfield MA
Endocrinology; 1979 Jul; 105(1):276-83. PubMed ID: 446410
[No Abstract] [Full Text] [Related]
25. [Neurochemical analysis of the mechanism of action of serotoninergic substances on avoidance behavior in situations of acute stress].
Shelekhov SL; Val'dman AV
Biull Eksp Biol Med; 1984 Apr; 97(4):423-6. PubMed ID: 6232963
[TBL] [Abstract][Full Text] [Related]
26. Specificity of serotoninergic involvement in the decrease of food intake induced by quipazine in the rat.
Samanin R; Bendotti C; Candelaresi G; Garattini S
Life Sci; 1977 Nov; 21(9):1259-66. PubMed ID: 270605
[No Abstract] [Full Text] [Related]
27. Structure-activity relationships in the actions of 1-phenyl-piperazines on brain serotonin receptors.
Fuller RW; Mason NR
Adv Exp Med Biol; 1981; 133():359-68. PubMed ID: 6172017
[No Abstract] [Full Text] [Related]
28. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
Friedman RL; Barrett RJ; Sanders-Bush E
J Pharmacol Exp Ther; 1984 Mar; 228(3):628-35. PubMed ID: 6707913
[TBL] [Abstract][Full Text] [Related]
29. Quipazine, a new type of antidepressant agent.
Rodríguez R; Pardo EG
Psychopharmacologia; 1971; 21(1):89-100. PubMed ID: 5567294
[No Abstract] [Full Text] [Related]
30. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
Fuller RW; Hemrick-Luecke SK; Snoddy HD
J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
[TBL] [Abstract][Full Text] [Related]
31. Differential neuroendocrine responses to the 5-HT agonist m-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley rats.
Aulakh CS; Wozniak KM; Hill JL; Devane CL; Tolliver TJ; Murphy DL
Neuroendocrinology; 1988 Oct; 48(4):401-6. PubMed ID: 2463494
[TBL] [Abstract][Full Text] [Related]
32. Recent studies with 4-chloramphetamine and some analogues.
Fuller RW; Molloy BB
Adv Biochem Psychopharmacol; 1974; 10():195-205. PubMed ID: 4846538
[No Abstract] [Full Text] [Related]
33. In vivo correlates of central serotonin function after high-dose fenfluramine administration.
Baumann MH; Ayestas MA; Rothman RB
Ann N Y Acad Sci; 1998 May; 844():138-52. PubMed ID: 9668672
[TBL] [Abstract][Full Text] [Related]
34. Effects of quipazine and methysergide on play in juvenile rats.
Normansell L; Panksepp J
Pharmacol Biochem Behav; 1985 May; 22(5):885-7. PubMed ID: 2989950
[TBL] [Abstract][Full Text] [Related]
35. Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine.
Cohen ML; Fuller RW
Life Sci; 1983 Feb; 32(7):711-8. PubMed ID: 6827905
[TBL] [Abstract][Full Text] [Related]
36. The effect of intracerebroventricularly administered octopamine, phenylethylamine and epinephrine on the central serotonergic system of the rat.
Jagiełło-Wójtowicz E
Pol J Pharmacol Pharm; 1982; 34(4):193-200. PubMed ID: 6820690
[TBL] [Abstract][Full Text] [Related]
37. Quipazine-induced head-twitch in mice.
Malick JB; Doren E; Barnett A
Pharmacol Biochem Behav; 1977 Mar; 6(3):325-9. PubMed ID: 140381
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacological properties of indolylalkyl derivatives of quipazine].
Trubitsyna TK; Kashkovskiĭ MD
Farmakol Toksikol; 1980; 43(5):530-6. PubMed ID: 7449980
[TBL] [Abstract][Full Text] [Related]
39. Parachloroamphetamine selectively alters regional cerebral metabolic responses to the serotonergic agonist metachlorophenylpiperazine in rats.
Freo U; Larson DM; Tolliver T; Rapoport SI; Soncrant TT
Brain Res; 1991 Mar; 544(1):17-25. PubMed ID: 1713115
[TBL] [Abstract][Full Text] [Related]
40. The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats.
Lawson DM; Gala RR
Endocrinology; 1978 Mar; 102(3):973-81. PubMed ID: 311279
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
